ADCT
Price
$4.11
Change
-$0.50 (-10.85%)
Updated
Oct 14 closing price
Capitalization
462.37M
27 days until earnings call
Intraday Buy/Sell Signals
NRIX
Price
$9.18
Change
-$0.54 (-5.56%)
Updated
Oct 14 closing price
Capitalization
705.41M
126 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ADCT vs NRIX

Header iconADCT vs NRIX Comparison
Open Charts ADCT vs NRIXBanner chart's image
ADC Therapeutics SA
Price$4.11
Change-$0.50 (-10.85%)
Volume$1.94M
Capitalization462.37M
Nurix Therapeutics
Price$9.18
Change-$0.54 (-5.56%)
Volume$1.27M
Capitalization705.41M
ADCT vs NRIX Comparison Chart in %
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. NRIX commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (ADCT: $4.11 vs. NRIX: $9.18)
Brand notoriety: ADCT and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 215% vs. NRIX: 125%
Market capitalization -- ADCT: $462.37M vs. NRIX: $705.41M
ADCT [@Biotechnology] is valued at $462.37M. NRIX’s [@Biotechnology] market capitalization is $705.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • ADCT’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, ADCT is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 4 bullish, 4 bearish.
  • NRIX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ADCT and NRIX are a good buy in the short-term.

Price Growth

ADCT (@Biotechnology) experienced а -4.64% price change this week, while NRIX (@Biotechnology) price change was -6.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

ADCT is expected to report earnings on Nov 11, 2025.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($705M) has a higher market cap than ADCT($462M). ADCT YTD gains are higher at: 106.533 vs. NRIX (-51.274). ADCT has higher annual earnings (EBITDA): -115M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. ADCT (265M). NRIX has less debt than ADCT: NRIX (56.5M) vs ADCT (118M). NRIX has higher revenues than ADCT: NRIX (83.7M) vs ADCT (77.2M).
ADCTNRIXADCT / NRIX
Capitalization462M705M66%
EBITDA-115M-248.7M46%
Gain YTD106.533-51.274-208%
P/E RatioN/AN/A-
Revenue77.2M83.7M92%
Total Cash265M429M62%
Total Debt118M56.5M209%
TECHNICAL ANALYSIS
Technical Analysis
ADCTNRIX
RSI
ODDS (%)
Bearish Trend 8 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
90%
Momentum
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 8 days ago
80%
MACD
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 8 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 8 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
75%
Bullish Trend 8 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
Bearish Trend 23 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
88%
Aroon
ODDS (%)
Bullish Trend 8 days ago
74%
Bearish Trend 8 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RESGX16.810.11
+0.66%
Glenmede Environmental Accountability
TIIRX29.24N/A
N/A
Nuveen Core Equity A
PURYX61.17-0.02
-0.03%
Putnam U.S. Research Y
BRXIX16.70-0.06
-0.36%
MFS Blended Research Intl Eq I
WIIGX23.45-0.13
-0.55%
Wasatch International Growth Instl

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
-10.85%
QTTB - ADCT
45%
Loosely correlated
-2.03%
VTYX - ADCT
45%
Loosely correlated
-1.62%
CLRB - ADCT
40%
Loosely correlated
+1.64%
NRIX - ADCT
39%
Loosely correlated
-5.56%
RGNX - ADCT
39%
Loosely correlated
-0.79%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-5.56%
KYMR - NRIX
66%
Closely correlated
-2.72%
DNLI - NRIX
58%
Loosely correlated
+1.54%
IDYA - NRIX
58%
Loosely correlated
+1.12%
NUVL - NRIX
55%
Loosely correlated
-5.67%
SYRE - NRIX
55%
Loosely correlated
+11.02%
More